Annual Report & Other Reports

Annual Report & Other Reports By Year: All | 2021 | 2020 | 2019 | 2018

24 Aug 2021 SAC Capital’s Equity Research – Strongest 1H Recorded
28 Jun 2021 KGI Securities’ Equity Research – A Fresh Start
17 May 2021 Sustainability Report 2020
12 Apr 2021 Annual Report 2020
17 Mar 2021 SAC Capital’s Equity Research – Growing Regional Presence
05 Mar 2021 PhillipCapital’s Equity Research – Not to Be Written Off
19 Nov 2020 SAC Capital’s Equity Research – Q3 Setback, Longer-Term Growth is Priority
16 Nov 2020 KGI Securities’ Equity Research – Short Term Speed Bump in the Pursuit of Growth
16 Nov 2020 PhillipCapital’s Equity Research – Repositioning for Growth
06 Nov 2020 KGI Securities’ Equity Research – Skin is the game
29 Sep 2020 Lim & Tan Securities’ Equity Research – Special Report
31 Aug 2020 SAC Capital’s Equity Research – Broadening Product Range and Footprints
24 Aug 2020 KGI Securities’ Equity Research – A Hair-Raising First Half
20 Aug 2020 PhillipCapital’s Equity Research – Shaking Off COVID-19 Woes with Expanded Portfolio
20 Jul 2020 PhillipCapital’s Equity Research – Building Channels to Establish Business Longevity
26 May 2020 Sustainability Report 2019
15 May 2020 RHB’s Equity Research – Numbers Improve During Pandemic; Stay BUY
08 Apr 2020 Annual Report 2019
04 Mar 2020 RHB’s Equity Research – Near-Term Outlook Uncertain Due to COVID-19; BUY Maintained
22 Nov 2019 SAC Capital’s Equity Research – 3Q2019 Results Review
20 Nov 2019 RHB’s Equity Research – Banking on Ceradan Products; Keep Buy
08 Nov 2019 SAC Capital’s Equity Research – Healthy Prospects in ASEAN
22 Oct 2019 PhillipCapital’s Equity Research – Leveraging on Trust with Doctors for Profitability
20 Aug 2019 RHB’s Equity Research – Ceradan Leading The Pack; Keep Buy
03 Jul 2019 RHB’s Equity Research – Hyphens Pharma: Undervalued and Under-Covered; Initiate BUY
31 Dec 2018 Annual Report 2018
11 May 2018 IPO Offer Document
31 Dec 2018 Annual Report 2018
11 May 2018 IPO Offer Document